Enanta Pharmaceuticals, Inc
Veridion Score
Composite trend over time
Why is ENTA moving today?
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ENTA.
ENTA insider activity
Enanta Pharmaceuticals, Inc
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for ENTA.
ENTA contract awards, year to date.
Public federal awards linked to this ticker.
ENTA lobbying filings, year to date.
Registered lobbying filings matched to Enanta Pharmaceuticals, Inc.